Transcriptomic Analyses Identify Key Differentially Expressed Genes and Clinical Outcomes Between Triple-Negative and Non-Triple-Negative Breast Cancer

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s187151
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Transgelin: A Potentially Useful Diagnostic Marker Differentially Expressed in Triple-Negative and Non–triple-Negative Breast Cancers

Human Pathology
Forensic MedicinePathology
2015English

Triple-Negative Breast Cancer

2018English

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction With Clinical Outcome

PLoS ONE
Multidisciplinary
2014English

Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2013English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

Incidence and Clinical Profile of Triple Negative Breast Cancer in Kashmir

Journal of Medical Science And clinical Research
2017English

The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer

Cancer Management and Research
Oncology
2018English

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2016English

Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy